Distinguishing Truncated and Normal MUC1 Glycoform Targeting from Tn-MUC1-Specific CAR T Cells: Specificity Is the Key to Safety

被引：20
|
作者：
Posey, Avery D., Jr. [1 ,2 ]
Clausen, Henrik [3 ,4 ]
June, Carl H. [1 ,2 ]
机构：
[1] Univ Penn, Ctr Cellular Immunotherapies, Philadelphia, PA 19104 USA
[2] Univ Penn, Parker Inst Canc Immunotherapy, Philadelphia, PA 19104 USA
[3] Univ Copenhagen, Fac Hlth Sci, Copenhagen Ctr Glyc, Dept Cellular & Mol Med, Blegdamsvej 3, DK-2200 Copenhagen N, Denmark
[4] Univ Copenhagen, Fac Hlth Sci, Copenhagen Ctr Glyc, Dept Odontol, Blegdamsvej 3, DK-2200 Copenhagen N, Denmark
来源：
IMMUNITY | 2016年 / 45卷 / 05期
关键词：
CHIMERIC ANTIGEN RECEPTOR; PROTEIN;
D O I：
10.1016/j.immuni.2016.10.015
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
引用
收藏
页码：947 / 948
页数：2
相关论文
共 50 条
  • [31] Modulation of MUC1 mucin as an escape mechanism of breast cancer cells from autologous cytotoxic T-lymphocytes
    Kontani, K
    Taguchi, O
    Narita, T
    Izawa, M
    Hiraiwa, N
    Zenita, K
    Takeuchi, T
    Murai, H
    Miura, S
    Kannagi, R
    BRITISH JOURNAL OF CANCER, 2001, 84 (09) : 1258 - 1264
  • [32] Early in vivo signaling profiles in MUC1-specific CD4+ T cells responding to two different MUC1-targeting vaccines in two different microenvironments
    Reichenbach, Dawn K.
    Finn, Olivera J.
    ONCOIMMUNOLOGY, 2013, 2 (03)
  • [33] Targeting of antigens to B cells augments antigen-specific T-cell responses and breaks immune tolerance to tumor-associated antigen MUC1
    Ding, Chuanlin
    Wang, Li
    Marroquin, Jose
    Yan, Jun
    BLOOD, 2008, 112 (07) : 2817 - 2825
  • [34] Induction of specific cytotoxic T lymphocytes (CTL) against ovarian cancer by MUC1/Y gene-modified dendritic cells
    Qi, L
    Kong, BH
    Yang, MX
    Qu, X
    Wei, MQ
    JOURNAL OF GENE MEDICINE, 2005, 7 (08): : 1133 - 1133
  • [35] Tandem CAR-T cells targeting MUC1 and PSCA combined with anti-PD-1 antibody exhibit potent preclinical activity against non-small cell lung cancer
    Wang, Aying
    Lv, Tangfeng
    Song, Yong
    CELLULAR IMMUNOLOGY, 2023, 391
  • [36] Lack of effective MUC1 tumor antigen-specific immunity in MUC1-transgenic mice results from a Th/T regulatory cell imbalance that can be corrected by adoptive transfer of wild-type Th cells
    Turner, Michael S.
    Cohen, Patrice A.
    Finn, Olivera J.
    JOURNAL OF IMMUNOLOGY, 2007, 178 (05): : 2787 - 2793
  • [37] Therapeutic effect of dual CAR-T targeting PDL1 and MUC16 antigens on ovarian cancer cells in mice
    Li, Tong
    Wang, Jiandong
    BMC CANCER, 2020, 20 (01)
  • [38] Therapeutic effect of dual CAR-T targeting PDL1 and MUC16 antigens on ovarian cancer cells in mice
    Tong Li
    Jiandong Wang
    BMC Cancer, 20
  • [39] Naturally processed class II epitope from the tumor antigen MUC1 primes human CD4+ T cells
    Hiltbold, EM
    Ciborowski, P
    Finn, OJ
    CANCER RESEARCH, 1998, 58 (22) : 5066 - 5070
  • [40] Cytotoxic T lymphocytes derived from bone marrow mononuclear cells of multiple myeloma patients recognize an underglycosylated form of MUC1 mucin
    Noto, H
    Takahashi, T
    Makiguchi, Y
    Hayashi, T
    Hinoda, Y
    Imai, K
    INTERNATIONAL IMMUNOLOGY, 1997, 9 (05) : 791 - 798
12345